Intravitreal triamcinolone for intraocular inflammation and associated macular edema

References

• MachemerRSugitaGTanoYTreatment of intraocular proliferations with intravitreal steroidsTrans Am Ophthalmol Soc197971718545825
   PubMedGoogle Scholar
• JonasJBHaylerJKPanda-JonesSIntravitreal injection of crystaline cortisone as adjunctive treatment of proliferative vitreoretinopathyBr J Ophthalmol2000851064710966969
   PubMed Web of Science ®Google Scholar
• MunirWMPulidoJSSharmaMCBuerkBMIntravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathyCan J Ophthalmol20054059860416391623
   PubMed Web of Science ®Google Scholar
• JonasJBKressigIKamppeterBDegenrinRFIntravitreal triamcinolone acetonide for the treatment of intraocular oedematous and neovascular diseasesOphthalmology200410111320
   Web of Science ®Google Scholar
• GilliesMCLarssonJThe effect of intravitreal triamcinolone on foveal edema in exudative macular degenerationAm J Ophthalmol2007144134517601437
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigISoefkerADegenringRFIntravitreal injection of triamcinolone for diffuse diabetic macular edemaArch Ophthalmol2003121576112523885
   PubMed Web of Science ®Google Scholar
• MartidisADukerDJGreenbergPBIntravitreal triamcinolone for refractory diabetic macular edemaOphthalmology2002109920711986098
   PubMed Web of Science ®Google Scholar
• ArgentiDJensenBKHenselRA balance study to evaluate the biotransformation and excretion of [14C] triamcinolone acetonide following oral administrationJ Clin Pharmacol2000407708010883419
   PubMed Web of Science ®Google Scholar
• DuguidIGBoydAWMandelTEAdhesion molecules are expressed in the human retina and choroidCurr Eye Res200011Suppl15391424741
   PubMed Web of Science ®Google Scholar
• FlomanNZorUMechanism of steroid action in ocular inflammation: inhibition of prostaglandin productionInvest Ophthalmol1977166973
   Google Scholar
• LewisGDCampbellWBJohnsonARInhibition of prostaglandin synthesis by glucocorticoids in human endothelial cellEndocrinology19861996293087737
   PubMed Web of Science ®Google Scholar
• FischerSRenzDSchaperWKarliczekGFIn vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factorEur J Pharmacol200141132314311164380
   PubMed Web of Science ®Google Scholar
• SommerAVeraartJNeumannMEvaluation of vasoconstrictive effects of topical steroids by lasesr-Doppler-perfusion-imagingActa Derm Venereol1998781589498019
   PubMed Web of Science ®Google Scholar
• BandiNKompellaUBBudesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cellsEur J Pharmacol20014251091611502275
   PubMed Web of Science ®Google Scholar
• WilsonCABerkowitzBASatoYTreatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulationArch Ophthalmol1992110115591497531
   PubMed Web of Science ®Google Scholar
• JermakCMDellacroceJTHeffezJPeymanGTriamcinolone acetonide in ocular therapeuticsSurv Ophthalmol20075255032217719372
   PubMed Web of Science ®Google Scholar
• WangYSFriedrichsUEichlerWHoffmannSWiedemannPInhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cellsGraefes Arch Clin Exp Ophthalmol2002240142811954780
   PubMed Web of Science ®Google Scholar
• KramerMEhrlichRSnirMIntravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet’s diseaseAm J Ophthalmol20041384666715488806
   PubMed Web of Science ®Google Scholar
• TuncerSYilmazSUrganciogluMTugal-TutkunIResults of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behcet diseaseJ Ocul Pharmacol Ther200723439540117803439
   PubMed Web of Science ®Google Scholar
• AtmacaLSYalcindagFNOzdemirOIntravitreal triamcinolone acetonide in the management of cystoid macular edema in Behcet’s diseaseGraefes Arch Clin Exp Ophthalmol20072453451617226025
   PubMed Web of Science ®Google Scholar
• KaracorluMMudunBOzdemirHKaracorluSABurumcekEIntravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet diseaseAm J Ophthalmol200413822899115289142
   PubMed Web of Science ®Google Scholar
• OhguroNYamanakaEOtoriYSaishinYTanoYRepeated intravitreal triamcinolone injections in Behcet disease that is resistant to conventional therapy: one-year resultsAm J Ophthalmol200614112182016387012
   PubMed Web of Science ®Google Scholar
• OzdemirHKaracorluMKaracorluSIntravitreal triamcinolone acetonide in sympathetic ophthalmiaGraefes Arch Clin Exp Ophthalmol20052437734615756580
   PubMed Web of Science ®Google Scholar
• JonasJBSpandauUHRepeated intravitreal triamcinolone acetonide for chronic sympathetic ophthalmiaActa Ophthalmolo Scand2006843436
   Google Scholar
• ChanRVSeiffBDLincoffHAColemanDJRapid recovery of sympathetic ophthalmia with treatment augmented by intravitreal steroidsRetina20062622432416467694
   PubMed Web of Science ®Google Scholar
• JonasJBIntravitreal triamcinolone acetonide for treatment of sympathetic ophthalmiaAm J Ophthalmol20041372367814962439
   PubMed Web of Science ®Google Scholar
• KaracorluMArf KaracorluSOzdemirHIntravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada sydromeEur J Ophthalmol2006163481316761256
   PubMed Web of Science ®Google Scholar
• AndradeREMuccioliCFarahMENussenblattRBBelfortRJrIntravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndromeAm J Ophthalmol20041373572415013890
   PubMed Web of Science ®Google Scholar
• MorekerMRLodhiSAPathengayARole of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada diseaseIndian J Ophthalmol20075564798017951914
   PubMedGoogle Scholar
• JabsDAVan NattaMLKempenJHCharacteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapyAm J Ophthalmol2002133486111755839
   PubMed Web of Science ®Google Scholar
• SirimaharajMRobinsonMRZhuMIntravitreal injection of triamcinolone acetonide for immune recovery uveitisRetina20062655788016770266
   PubMed Web of Science ®Google Scholar
• MorrisonVLKozakILaBreeLDIntravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edemaOphthalmology20071142334917270681
   PubMed Web of Science ®Google Scholar
• WeissHAnlesslyWJShieldJAThe clinical course of serpiginous retinochoroidopathyAm J Ophthalmol19798713342434065
   PubMed Web of Science ®Google Scholar
• AdiguzelUSariAOzmenCOzOIntravitreal triamcinolone acetonide treatment for serpiginous choroiditisOcul Immunol Inflamm2006146375817162609
   PubMed Web of Science ®Google Scholar
• PathengayAIntravitreal triamcinolone acetonide in serpiginous choroidopathyIndian J Ophthalmol200553177915829756
   PubMedGoogle Scholar
• KaracorluSOzdemirHKaracorluMIntravitreal triamcinolone acetonide in serpiginous choroiditisJpn J Ophthalmol2006502849816767387
   PubMed Web of Science ®Google Scholar
• ShahABranleyMUse of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: a case study over a three-year periodClin Exp Ophthalmol20053344424
   Web of Science ®Google Scholar
• MartidisADukerJSPuliafitoCAIntravitreal triamcinolone for refractory cystoid macular edema with birdshot retinochoroidopathyArch Ophthalmol20011191380311545651
   PubMedGoogle Scholar
• YenerlNMGorgunEDincUAOncelMTreatment of cystoid macular edema due to acute posterior multifocal placoid pigment epitheliopathyOcul Immunol Inflamm200816677118379948
   PubMed Web of Science ®Google Scholar
• ChoudhrySGhoshSIntravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedemaClin Exp Ophthalmol20073587138
   Web of Science ®Google Scholar
• DegenringRFJonasJBIntravitreal injection of triamcinolone acetonide as treatment for chronic uveitisBr J Ophthalmol200387336112598455
   PubMed Web of Science ®Google Scholar
• OzkirisAIntravitreal triamcinolone acetonide injection for the treatment of posterior uveitisOcul Immunol Inflamm2006144233816911985
   PubMed Web of Science ®Google Scholar
• OkhraviNMorrisAKokHSIntraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot studyJ Cataract Refract Surg200733712788317586387
   PubMed Web of Science ®Google Scholar
• AngunawelaRIHeatleyCJWilliamsonTHIntravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcomeActa Ophthalmol Scand2005835595916187999
   PubMedGoogle Scholar
• AndrewsRMKokHLauCMaycockNMcCluskeyPLightmanSEffectiveness of intravitreal triamcinolone acetate in refractory uveitic cystoid macular oedemaInvestig Ophthalmol Vis Sci20054615623753
   PubMed Web of Science ®Google Scholar
• KokHLauCMaycockNMcCluskeyPLightmanSOutcome of intravitreal triamcinolone in uveitisOphthalmology2005112111916.e1716171868
   PubMed Web of Science ®Google Scholar
• Das-BhaumikRGJonesNPLow-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitisEye2006208934716096656
   PubMed Web of Science ®Google Scholar
• Tay-KearneyMLIntravitreal triamcinolone acetonide injection for the treatment of posterior uveitisOcul Immunol Inflamm200614201216911980
   PubMed Web of Science ®Google Scholar
• KooijBVRothovaAde VriesPThe pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edemaOcul Immunol Inflamm200614738516597536
   PubMed Web of Science ®Google Scholar
• SorensenTLHaamannPVillumsenJLarsenMIntravitreal triamcinolone for macular oedema: efficacy in relation to aetiologyActa Ophthalmol Scand2005831677015715560
   PubMedGoogle Scholar
• IrvineSRA newly defined vitreous syndrome following cataract surgeryAm J Ophthal195336599619
   PubMed Web of Science ®Google Scholar
• IrvineSRCystoid MaculopathySurv Ophthalmol197621117785652
   PubMedGoogle Scholar
• KraffMCSandersDRJampolLMLiebermanHLFactors affecting pseudophakic cystoid macular edema: five randomized trialsAm Intra-ocular Implant Soc J1985113805
   Google Scholar
• Guex-CrosierYThe pathogenesis and clinical presentation of macular edema in inflammatory diseaseDoc Ophthalmol19999729730910896343
   PubMed Web of Science ®Google Scholar
• KraffMCSandersDRJampolLMLiebermanHLEffect of primary capsulotomy with extracapsular surgery on the incidence of pseudophakic cystoid macular oedemaAm J Ophthalmol198498166706476044
   PubMed Web of Science ®Google Scholar
• WrightPLWilkinsonCPBalyeatHDAngiographic cystoid macular oedema after posterior chamber lens implantationArch Ophthalmol10674043369996
   PubMedGoogle Scholar
• YannuzziLAA perspective on the treatment of aphakic cystoid macular oedemaSurv Ophthalmol198428540536379952
   PubMed Web of Science ®Google Scholar
• JampolLMPharmacologic therapy of aphakic and pseudophakic cystoid macular oedema: 1985 updateOphthalmology198592807103897936
   PubMed Web of Science ®Google Scholar
• LevyJHPisaconaAMClinical experience with Nd:YAG laser vitreolysis in the anterior segmentJ Cataract Refract Surg198713548503668839
   PubMed Web of Science ®Google Scholar
• SucklingRDMaslinKFPseudophakic cystoid macular oedema and its treatment with local corticosteroidsAust N Z J Ophthalmol19881635393248184
   PubMedGoogle Scholar
• PendergastSDMagherioRRWilliamsGACosMSVitrectomy for chronic pseudophakic cystoid macular edemaAm J Ophthalmol19991283172310511026
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigIDegenringRFIntravitreal triamcinolone acetonide for pseudophakic cystoid macular edemaAm J Ophthalmol20031362384612888077
   PubMed Web of Science ®Google Scholar
• BosciaFFurinoCDammaccoRFerreriPSborgiaLSborgiaCIntravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: Functional and anatomic resultsEur J Ophthalmol2005151899515751245
   PubMed Web of Science ®Google Scholar
• KoutsandreaCMoschosMMBrouzaDLoukianouEApostolopoulosMMoschosMIntraocular triamcinolone for pseudophakic cystoid macular edema: Optical coherence tomography and multifocal electroretinography studyRetina20072721596417290196
   PubMed Web of Science ®Google Scholar
• BenhamouNMassinPHaouchineBAudrenFTadayoniRGaudricAIntravitreal triamcinolone for refractory pseudophakic macular edemaAm J Ophthal20031352246912566041
   PubMed Web of Science ®Google Scholar
• ConwayMDCanakisCLivir-RallatosCPeymanGAIntravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edemaJ Cataract Refract Surg200329273312551663
   PubMed Web of Science ®Google Scholar
• KaracorluMOzdemirHKaracorluSIntravitreal triamcinolone actetonide for the treatment of chronic pseudophakic cystoid macular oedemaActa Ophthal Scand20038164852
   PubMedGoogle Scholar
• JonasJBKamppeterBIntravitreal triamcinolone acetonide for persisting cystoid macular edema after penetrating keratoplastyCornea200625240116371793
   PubMed Web of Science ®Google Scholar
• ThompsonJTCataract formation and other complications of intravitreal triamcinolone for macular edemaAm J Ophthalmol200614146293716564796
   PubMed Web of Science ®Google Scholar
• Van KooijBRothovaAde VriesPThe pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edemaOcul Immunol Inflamm200614738516597536
   PubMed Web of Science ®Google Scholar
• GilliesMCSimpsonJMBillsonFASafety of an intravitreal injection of triamcinolone: results from a randomized clinical trialArch Ophthalmol20041223364015006845
   PubMed Web of Science ®Google Scholar
• GillesMCKuzniarzMCraigJIntravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataractOphthalmology20051121394315629834
   PubMed Web of Science ®Google Scholar
• WingateRJBeaumontPEIntravitreal triamcinolone and elevated intraocular pressureAust NZ J Ophthalmol1999274312
   PubMedGoogle Scholar
• SmithenLMOberMDMarananLSpaideRFIntravitreal triamcinolone acetonide and intraocular pressureAm J Ophthalmol2004138740315531307
   PubMed Web of Science ®Google Scholar
• GalorAMargolisRBrasilOMFAdverse events after intravitreal triamcinolone in patients with and without uveitisOphthalmololgy200711419128
   PubMed Web of Science ®Google Scholar
• Detry-MorelMEscarmelleAHermansIRefractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonideBull Soc Belge Ophthalmol20042924551
   PubMedGoogle Scholar
• JonasJBDegenringRFKreissigIIntraocular pressure elevated after intravitreal triamcinolone acetonide injectionOphthalmology2005112593815808249
   PubMed Web of Science ®Google Scholar
• AgrawalSAgrawalJAgrawalTPVitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonideAm J Ophthalmol20041386798015488813
   PubMed Web of Science ®Google Scholar
• MoshfeghiDMKaiserPKScottIUAcute endophthalmitis following intravitreal triamcinolone acetonide injectionAm J Ophthalmol20031365791614597028
   PubMed Web of Science ®Google Scholar
• JagerRDAielloLPPatelSCCunninghamETJrRisks of intravitreous injection: a comprehensive reviewRetina2004246769815492621
   PubMed Web of Science ®Google Scholar
• BhavsarARIpMSGlassmanARThe risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trialsAm J Ophthalmol20071443454617765429
   PubMed Web of Science ®Google Scholar
• BakriSJShahAFalkNSBeerPMIntravitreal preservative-free triamcinolone acetonide for the treatment of macular oedemaEye2005196686815332099
   PubMed Web of Science ®Google Scholar
• MoshfeghiDMKaiserPKBakriSJPresumed sterile endophthalmitis following intravitreal triamcinolone acetonide injectionOphthalmic Surg Lasers Imaging200536124915688968
   PubMed Web of Science ®Google Scholar
• MaiaMFarahMEBelfortRNEffects of intravitreal triamcinolone acetonide injection with and without preservativeBr J Ophthalmol20079191122417383993
   PubMed Web of Science ®Google Scholar
• NelsonMLTennantMTSivalingamARegilloCDBelmontJBMartidisAInfectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injectionRetina20032356869114574256
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigISpandauUHHarderBInfectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideAm J Ophthalmol200614135798016490517
   PubMed Web of Science ®Google Scholar
• MoshfeghiAAScottIUFlynnHWPuliafitoCAPseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edemaAm J Ophthalmol200413834899215364241
   PubMed Web of Science ®Google Scholar
• AndroudiSLetkoEMeniconiMSafety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edemaOcular Immunol Inflamm20051320512
   PubMed Web of Science ®Google Scholar
• SrinivasanSPrasadSConjunctival necrosis following intravitreal injection of triamcinolone acetonideCornea20052481027816227858
   PubMed Web of Science ®Google Scholar